Viewing Study NCT06503471



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06503471
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-02

Brief Title: SCLife-UT hUC-MSCs Advanced Therapy Medicinal Products hUC-MSCs ATMPs for Patients With Thin Endometrial Infertility
Sponsor: None
Organization: None

Study Overview

Official Title: A Clinical Research on SCLife-UT hUC-MSCs Advanced Therapy Medicinal Products hUC-MSCs ATMPs for Patients With Thin Endometrial Infertility
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To explore the therapeutic effect and safety of human umbilical cord mesenchymal stem cells on thin endometrial infertility and to explore whether human umbilical cord mesenchymal stem cells using collagen as the carrier can promote endometrial growth reduce the recurrence rate of intrauterine adhesion increase the clinical pregnancy rate improve the pregnancy outcome and study its safety
Detailed Description: This is a random open label and self-control experiment 24 patients are selected and sign consent forms then divided into two groups Doctors collect the basic information of patient including age BMI mental condition vital sign history of disease pharmaco-history and so on evaluate the symptom of thin endometrial infertility menstrual conditions uterine cavity form pregnancies

All patients receive laboratory and image examination as baseline Then cell treatment will be given based on the clinical protocol Doctors have follow-up visit on 1 3 6 12 month after treatment and do efficacy evaluation

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None